IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS

The T lymphocyte is muromonab-CD3 for testing the effect of immunotherapy on a cancer patient in a skin test

Saved in:

Bibliographic Details
Main Author	HADDEN, JOHN, W
Format	Patent
Language	English French German
Published	02.12.2009
Subjects	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING
Online Access	Get full text

Loading…

More Information
Summary:	The T lymphocyte is muromonab-CD3 for testing the effect of immunotherapy on a cancer patient in a skin test
Bibliography:	Application Number: EP20080729957